Um die volle Funktionalität der Webseite nutzen zu können, müssen Sie JavaScript in ihrem Browser aktivieren.

DAX19.390,04+0,87 %

Gold2.655,75+0,99 %

Öl (Brent)79,04-0,57 %

Dow Jones42.865,63+0,97 %

US Tech 10020.269,38+0,14 %

EUR/USD1,09371+0,01 %

Top 15 der gesamten Suchanfragen der letzten 7 Tage

Login

Reneo Pharmaceuticals Aktie

Aktie

ISIN: US75974E1038 WKN: A3CMW7 SYM: RPHM Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

1,8200

USD

+5,20 %

+0,0900 USD

Letzter Kurs 05.10.24 Nasdaq

Geldkurs

04.10.24

1,8200

USD

11.900 STK

Briefkurs

04.10.24

1,8400

USD

900 STK

Reneo Pharmaceuticals Aktie kaufen

Neueste Nachrichten

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million 04.10.24 · globenewswire · Reneo Pharmaceuticals
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure 03.10.24 · globenewswire · Reneo Pharmaceuticals
RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders 03.09.24 · Business Wire (engl.) · Reneo Pharmaceuticals
RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM 29.08.24 · Business Wire (engl.) · Reneo Pharmaceuticals
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results 13.08.24 · globenewswire · Reneo Pharmaceuticals
RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM 15.05.24 · Business Wire (engl.) · Reneo Pharmaceuticals
RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders 13.05.24 · Business Wire (engl.) · Reneo Pharmaceuticals
Reneo Pharmaceuticals and OnKure Announce Proposed Merger 13.05.24 · globenewswire · Reneo Pharmaceuticals
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results 07.05.24 · globenewswire · Reneo Pharmaceuticals
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update 28.03.24 · globenewswire · Reneo Pharmaceuticals
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) 14.12.23 · globenewswire · Reneo Pharmaceuticals
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results 13.11.23 · globenewswire · Reneo Pharmaceuticals

1
2

Meistgelesen

7 Tage
30 Tage
12 Monate

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of ... 900 Leser

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of ... 900 Leser
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure 108 Leser

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of ... 900 Leser
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results 312 Leser
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results 196 Leser
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary ... 192 Leser
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings 172 Leser
Reneo Pharmaceuticals and OnKure Announce Proposed Merger 148 Leser
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results 132 Leser
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business ... 116 Leser
RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM 112 Leser
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure 108 Leser